Risk factors and outcomes associated with Left Ventricular Thrombus in patients with Peripartum Cardiomyopathy: An

Kritika Luthra1, Sindhu R Avula2, Murugesan Raju3

  • 1Mercy St. Vincent Medical Center, Toledo, OH, USA.

Insights

Peripartum cardiomyopathy (PPCM) patients with left ventricular thrombus (LVT) face increased risks of stroke and longer hospital stays. Aggressive risk factor modification is crucial for high-risk PPCM patients with LVT.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Obstetrics

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.
  • Left ventricular thrombus (LVT) is a potential complication of PPCM.
  • The prevalence and impact of LVT in PPCM patients require further investigation.

Purpose of the Study:

  • To determine the prevalence of left ventricular thrombus (LVT) in patients diagnosed with peripartum cardiomyopathy (PPCM).
  • To evaluate the impact of LVT on clinical outcomes and hospital resource utilization in PPCM patients.

Main Methods:

  • A retrospective cohort study utilizing the Nationwide Inpatient Sample database (2005-2014).
  • Analysis included admissions with PPCM as the primary diagnosis.
  • Univariate and multivariable logistic regression analyses were performed to assess risk factors and outcomes.

Main Results:

  • Over 43,000 PPCM admissions were identified, with 452 cases of LVT.
  • Black race, smoking, drug abuse, and hypertension were associated with higher LVT incidence.
  • LVT patients experienced longer hospital stays, higher hospitalization charges, and increased stroke rates, but not significantly different in-hospital mortality.

Conclusions:

  • Left ventricular thrombus (LVT) is associated with poorer outcomes in peripartum cardiomyopathy (PPCM) patients, including increased stroke risk and prolonged hospitalization.
  • Certain demographic and comorbidity profiles (e.g., Black race, diabetes with complications, coagulopathy) indicate higher LVT prevalence.
  • Targeted risk factor modification is essential for high-risk PPCM patients with LVT to mitigate adverse events.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
80
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
47
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
72
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
49
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
57
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
63